Wednesday, February 6, 2013

Dapoxetine and PDE5i in PE

Dapoxetine and PDE5i in PE - Dapoxitine only approved in some countries including Korea, Rapid acting & short half-life SSRI with a pharmacokinetic profile suggesting a role as on-demand treatment for PE.

No comments:

Post a Comment